@article{ref1,
title="World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders",
journal="World journal of biological psychiatry",
year="2013",
author="Bauer, M. and Pfennig, A. and Severus, E. and Whybrow, P.C. and Angst, J. and Moller, H.-j. and Adli, M. and Benkert, O. and Bschor, T. and Tadić, A. and Holsboer-Trachsler, E. and Anderson, I. and Baldwin, D. and Cookson, J.C. and Grunze, H. and Katona, C. and Paykel, E.S. and Tylee, A. and Ayuso-Gutierrez, J.L. and Vieta, E. and Bech, P. and Licht, R.W. and Lublin, H. and Vestergaard, P. and Berk, M. and Burrows, G. and Mitchell, P.B. and Schweitzer, I. and Bitter, I. and Cassano, G. and Cetkovich-Bakmas, M. and Da Costa, D. and Gheorghe, M.D. and Heinze, G. and Higuchi, T. and Hirschfeld, R.M.A. and Keller, M.B. and Kupfer, D.J. and Rush, A.J. and Unützer, J. and Höschl, C. and Kang, R.-h. and Lee, M.-s. and Lim, S.-w. and Paik, J.-w. and Park, Y.C. and Kasper, S. and Kirli, S. and Yazici, A. and Kostukova, E. and Kulhara, P. and Leonard, B. and Lingjaerde, O. and Liu, C.-y. and Mendlewicz, J. and Puzyński, S. and Rybakowski, J.K. and Yamada, K.",
volume="14",
number="5",
pages="334-385",
abstract="OBJECTIVEs. This 2013 update of the practice guidelines for the biological treatment of unipolar depressive disorders was developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). The goal has been to systematically review all available evidence pertaining to the treatment of unipolar depressive disorders, and to produce a series of practice recommendations that are clinically and scientifically meaningful based on the available evidence. The guidelines are intended for use by all physicians seeing and treating patients with these conditions. <br><br>METHODS. The 2013 update was conducted by a systematic update literature search and appraisal. All recommendations were approved by the Guidelines Task Force. <br><br>RESULTS. This first part of the guidelines (Part 1) covers disease definition, classification, epidemiology, and course of unipolar depressive disorders, as well as the management of the acute and continuation phase treatment. It is primarily concerned with the biological treatment (including antidepressants, other psychopharmacological medications, electroconvulsive therapy, light therapy, adjunctive and novel therapeutic strategies) of adults. <br><br>CONCLUSIONS. To date, there is a variety of evidence-based antidepressant treatment options available. Nevertheless there is still a substantial proportion of patients not achieving full remission. In addition, somatic and psychiatric comorbidities and other special circumstances need to be more thoroughly investigated. Therefore, further high-quality informative randomized controlled trials are urgently needed. © 2013 Informa Healthcare.<p /><p>Language: en</p>",
language="en",
issn="1562-2975",
doi="10.3109/15622975.2013.804195",
url="http://dx.doi.org/10.3109/15622975.2013.804195"
}